Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | The impact of COVD-19 on advocacy networks

Lydia Makaroff • 10 Sep 2022
ESMO 2022
General

Lydia Makaroff, PhD, Fight Bladder Cancer and World Bladder Cancer Patient Coalition, Cambridge, UK, talks on the impact of COVD-19 on advocacy networks. Patient organizations have lost 70% of their volunteers on average during the pandemic and those with paid staff have lost 20%. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Lydia Makaroff

0:54
Role of patient advocacy in clinical trial design
Lydia Makaroff • 10 Sep 2022
0:41
Mitigating the effects of COVID-19 on advocacy networks
Lydia Makaroff • 10 Sep 2022
0:34
The aims of Fight Bladder Cancer and World Bladder Cancer Patient Coalition
Lydia Makaroff • 10 Sep 2022
0:34
The aims of Fight Bladder Cancer and World Bladder Cancer Patient Coalition
Lydia Makaroff • 10 Sep 2022

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals